Entries by Sofia Lindén

Forward-looking session on cancer precision medicine

Emerging therapies, digital solutions and AI were central topics when international experts met during the oncology session at the Nordic Life Science Days 2019. Oslo Cancer Cluster hosted the session on oncology titled “Cancer precision medicine: State-of-the-art and future directions” at the Nordic Life Science Days this year. The session covered recent advances in cancer […]

Together for precision medicine

During Arendalsuka 2019, we arranged a breakfast meeting on the development of cancer treatments of the future, together with LMI and Kreftforeningen. Arendalsuka has become an important arena for those who want to improve aspects of Norwegian society. We were there this year to meet key players to accelerate the development of cancer treatments. Our […]

Promising start for expansion group of Targovax clinical trial

Targovax, one of the members of Oslo Cancer Cluster, has begun an expansion patient group in the clinical trial of a drug to treat skin cancer. The company Targovax is developing immune activators to target solid tumours that are difficult to treat. The drug in question, called ONCOS-102, is aimed at patients with malignant melanoma (skin […]